WebCarboplatin is used to treat ovarian cancer. Carboplatin is also used for other types of cancer, including lung, head and neck, endometrial, esophageal, bladder, breast, and cervical; central nervous system or germ cell tumors; osteogenic sarcoma; and as preparation for a stem cell or bone marrow transplant. WebPemetrexed and cisplatin is a combination of cancer drugs. It is a treatment for lung cancer and mesothelioma. Find out about how you have it, possible side effects and other important information. ... For further information about this treatment go to the electronic Medicines Compendium (eMC) website. eMC website; You can report any side ...
HIGHLIGHTS OF PRESCRIBING INFORMATION - Food …
WebJul 11, 2024 · These effects of EMC-CM on cisplatin resistance were visualized with holotomographic microscopy images of IC 50 Cisplatin-treated SCC-25 cells using the NanoLIVE system. If SCC-25 cells were treated with cisplatin in albumin containing medium for 72 h the cells died and released their adhesion from the cell culture dish. WebSep 1, 2024 · Cisplatin, the active ingredient in Cisplatin for injection, USP, is a yellow to orange crystalline powder with the molecular formulaCl 2 H 6 N 2 Pt and a molecular weight of 300.05. Cisplatin is a heavy metal complex containing a central atom of platinum surrounded by two chloride atoms and two ammonia molecules in the cis position. chuck trainers
Taxotere European Medicines Agency
WebApr 19, 2024 · PLATINOL® (cisplatin for injection, USP) is a white to light yellow lyophilized powder. Each vial of PLATINOL contains 50 mg cisplatin, 450 mg Sodium Chloride, USP, and 500 mg Mannitol, USP. The active ingredient, cisplatin, is a yellow to orange crystalline powder with the molecular formula PtCl 2 H 6 N 2, and a molecular … WebSep 17, 2024 · Non-small-cell lung cancer Alimta in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small-cell … WebC, The AR promotes cell migration in the cisplatin-resistance EMC cells. The Ishi-par and Ishi-AR cells were treated with cisplatin for 14 days and then measured using wound-healing assay. Wound closure area (μm 2) was measured as described in the Methods section. D, The AR promotes EMT in the cisplatin-resistant EMC cells. chuck transportation